| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0064 | 1 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.0048 | 1 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |